Recall: D-0596-2018
Class I - Dangerous
Class IClassification
2018-02-07Initiated
TerminatedStatus
Pfizer Inc.Firm
Product
Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618. NDC: 0703-0110-01
Reason
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
Distribution
Nationwide in the USA
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.